BRIAN N SWANSON
Medical Practice in Yardley, PA
License number
New Jersey 25MS00002800
Issued Date
Apr 15, 1988
Expiration Date
Dec 31, 2005
Category
Medical Examiners
Type
Bioanalytical Lab Dir - Spec
Address
Address
Yardley, PA
Personal information
See more information about BRIAN N SWANSON at radaris.comName
Address
Phone
38565 Route 6, Bear Lake, PA 16402
30 Wenner Farm Ln, Robesonia, PA 19551
20 Dunham St, Sheffield, PA 16347
Professional information
Human Single Nucleotide Polymorphisms
US Patent:
2004003, Feb 19, 2004
Filed:
Jun 3, 2003
Appl. No.:
10/453827
Inventors:
Lester Hui - Fairfax VA, US
Mark Perrone - Boston MA, US
James Powell - Lumberville PA, US
Chandra Ramanathan - Wallingford CT, US
Brian Swanson - Yardley PA, US
Zenta Tsuchihashi - Skillman NJ, US
Kim Zerba - New Hope PA, US
Mark Perrone - Boston MA, US
James Powell - Lumberville PA, US
Chandra Ramanathan - Wallingford CT, US
Brian Swanson - Yardley PA, US
Zenta Tsuchihashi - Skillman NJ, US
Kim Zerba - New Hope PA, US
International Classification:
C12Q001/68, C07H021/04, C12N009/64, C12P021/02, C12N005/06
US Classification:
435/226000, 435/069100, 435/006000, 435/320100, 435/325000, 536/023200
Abstract:
The invention provides polynucleotides and polypeptides corresponding to novel gene sequences associated with the incidence of cardiovascular disorders. The invention also provides polynucleotide fragments corresponding to the genomic and/or coding regions of these genes which comprise at least one polymorphic site per fragment. Allele-specific primers and probes which hybridize to these regions, and/or which comprise at least one polymorphic site are also provided. The polynucleotides, primers, and probes of the present invention are useful in phenotype correlations, paternity testing, medicine, and genetic analysis. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders, particularly cardiovascular diseases related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Human Single Nucleotide Polymorphisms
US Patent:
2003011, Jun 19, 2003
Filed:
Dec 3, 2001
Appl. No.:
10/005956
Inventors:
Zenta Tsuchihashi - Pennington NJ, US
Lester Hui - Fairfax VA, US
Kim Zerba - New Hope PA, US
Manling Ma-Edmonds - Lawrenceville NJ, US
Mark Perrone - Princeton NJ, US
Brian Swanson - Yardley PA, US
James Powell - Lumberville PA, US
Lester Hui - Fairfax VA, US
Kim Zerba - New Hope PA, US
Manling Ma-Edmonds - Lawrenceville NJ, US
Mark Perrone - Princeton NJ, US
Brian Swanson - Yardley PA, US
James Powell - Lumberville PA, US
International Classification:
C12Q001/68, C07H021/04, C12N009/64, C12P021/02, C12N005/06
US Classification:
435/006000, 435/069100, 435/226000, 435/320100, 435/325000, 536/023200
Abstract:
The invention provides polynucleotides and polypeptides corresponding to novel gene sequences associated with the incidence of cardiovascular disorders. The invention also provides polynucleotide fragments corresponding to the genomic and/or coding regions of these genes which comprise at least one polymorphic site per fragment. Allele-specific primers and probes which hybridize to these regions, and/or which comprise at least one polymorphic site are also provided. The polynucleotides, primers, and probes of the present invention are useful in phenotype correlations, paternity testing, medicine, and genetic analysis. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders, particularly cardiovascular diseases related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.